Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Transforming biomedical research to develop effective TB vaccines: the next ten years.

Sizemore CF, Fauci AS.

Tuberculosis (Edinb). 2012 Mar;92 Suppl 1:S2-3. doi: 10.1016/S1472-9792(12)70003-3. No abstract available.

PMID:
22441154
2.

Tuberculosis vaccines: a strategic blueprint for the next decade.

Brennan MJ, Thole J.

Tuberculosis (Edinb). 2012 Mar;92 Suppl 1:S6-13. doi: 10.1016/S1472-9792(12)70005-7. No abstract available.

PMID:
22441160
3.

The blueprint for vaccine research & development: walking the path for better TB vaccines.

Lienhardt C, Fruth U, Greco M.

Tuberculosis (Edinb). 2012 Mar;92 Suppl 1:S33-5. doi: 10.1016/S1472-9792(12)70011-2. Review.

PMID:
22441158
4.

Creativity in tuberculosis research and discovery.

Younga D, Verreck FA.

Tuberculosis (Edinb). 2012 Mar;92 Suppl 1:S14-6. doi: 10.1016/S1472-9792(12)70006-9. Review.

PMID:
22441152
5.

TB vaccines: the paradigms they are a-shifting.

McMurray DN, Ly LH.

Expert Rev Vaccines. 2009 Dec;8(12):1615-8. doi: 10.1586/erv.09.131. No abstract available.

PMID:
19943755
6.

Update on research and development pipeline: tuberculosis vaccines.

Beresford B, Sadoff JC.

Clin Infect Dis. 2010 May 15;50 Suppl 3:S178-83. doi: 10.1086/651489. Review.

PMID:
20397946
7.

Antituberculous vaccine development: a perspective for the endemic world.

Verma I, Grover A.

Expert Rev Vaccines. 2009 Nov;8(11):1547-53. doi: 10.1586/erv.09.111. Review.

PMID:
19863247
8.

Bridging the gap: engaging researchers and advocates to build support for TB vaccine research and development.

Kennell M, Woolley J.

Tuberculosis (Edinb). 2012 Mar;92 Suppl 1:S30-2. doi: 10.1016/S1472-9792(12)70010-0.

PMID:
22441157
9.

The second Geneva Consensus: Recommendations for novel live TB vaccines.

Walker KB, Brennan MJ, Ho MM, Eskola J, Thiry G, Sadoff J, Dobbelaer R, Grode L, Liu MA, Fruth U, Lambert PH.

Vaccine. 2010 Mar 8;28(11):2259-70. doi: 10.1016/j.vaccine.2009.12.083. Epub 2010 Jan 20. Review.

PMID:
20074686
10.

Vaccination strategies to prevent tuberculosis in the new millennium: from BCG to new vaccine candidates.

Franco-Paredes C, Rouphael N, del Rio C, Santos-Preciado JI.

Int J Infect Dis. 2006 Mar;10(2):93-102. Epub 2005 Dec 22. Review.

11.

Ten challenges for TB biomarkers.

Ottenhoff TH, Ellner JJ, Kaufmann SH.

Tuberculosis (Edinb). 2012 Mar;92 Suppl 1:S17-20. doi: 10.1016/S1472-9792(12)70007-0.

PMID:
22441153
12.

A new TB vaccine blueprint.

Brennan PJ.

Tuberculosis (Edinb). 2012 Mar;92 Suppl 1:S1. doi: 10.1016/S1472-9792(12)00049-2. No abstract available.

PMID:
22441151
13.

Advances in tuberculosis vaccine strategies.

Skeiky YA, Sadoff JC.

Nat Rev Microbiol. 2006 Jun;4(6):469-76. Review.

PMID:
16710326
14.

Development of vaccines against tuberculosis.

Tyagi AK, Nangpal P, Satchidanandam V.

Tuberculosis (Edinb). 2011 Sep;91(5):469-78. doi: 10.1016/j.tube.2011.01.003. Epub 2011 Feb 18. Review.

PMID:
21334259
15.

New tuberculosis vaccines.

Martín Montañés C, Gicquel B.

Enferm Infecc Microbiol Clin. 2011 Mar;29 Suppl 1:57-62. doi: 10.1016/S0213-005X(11)70019-2. Review.

PMID:
21420568
16.

TB vaccines for the World.

Glyn Hewinson R.

Tuberculosis (Edinb). 2005 Jan-Mar;85(1-2):1-6. Epub 2005 Jan 17.

PMID:
15687020
17.

Performance of QuantiFERON TB in a student population at low risk of tuberculosis.

Molicotti P, Bua A, Zanetti S.

J Infect Dev Ctries. 2012 Jan 12;6(1):100-1. No abstract available.

18.

Questions for biotechs: AERAS.

Connolly J.

Hum Vaccin. 2010 Dec;6(12):962-3. doi: 10.4161/hv.6.12.14485. No abstract available.

PMID:
21487239
19.

Tuberculosis: vaccines in the pipeline.

Ly LH, McMurray DN.

Expert Rev Vaccines. 2008 Jul;7(5):635-50. doi: 10.1586/14760584.7.5.635. Review.

PMID:
18564018
20.

[New research on anti-tuberculosis vaccines].

Gao H, Dai WX, Huangpu YM.

Zhonghua Jie He He Hu Xi Za Zhi. 2003 Jan;26(1):36-8. Review. Chinese. No abstract available.

PMID:
12784801

Supplemental Content

Support Center